Acetylsalicylic acid Terminated Phase 4 Trials for Fontan Procedure Treatment

IndicationsStatusPurposePhase
TerminatedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02966002Aspirin as a Novel Anti-Inflammatory Modality in the Fontan Patients